How Genetic Sequencing is the Key to Personalized Cancer Care
Ron Levy, M.D. is professor and chief of the division of oncology at the Stanford School of Medicine. He has been a pioneer in the development of monoclonal antibodies for the treatment of cancer and a world renowned expert in cancer research and treatment with targeted therapies. In 2008 he was elected to the National Academy of Sciences.
Experts & Guests
Ronald Levy, M.D.
Professor and Chief, Division of Oncology, Stanford University School of MedicineDr. Ronald Levy is a professor of medicine and chief of the Division of Oncology at Stanford University School of Medicine. Dr. Levy attended medical school at Stanford University followed by an internship and residency in internal medicine at Massachusetts General Hospital. He went on to complete fellowships at Stanford University Medical Center and The Weizmann Institute of Science in... more >